From a genetic testing standpoint, the increasing use of whole exome/genome sequencing in acutely unwell infants presenting with cardiomyopathy will help define the full spectrum of clinical severity associated with biallelic NEXN variants. The gene discussed is NEXN; the disease is cardiomyopathy.